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Comparison of antioxidative effects between radon and thoron 1 
inhalation in mouse organs 2 
Background: Radon therapy has been traditionally performed globally for oxidative stress-3 
related diseases. Many researchers have studied the beneficial effects of radon exposure in 4 
living organisms. However, the effects of thoron, a radioisotope of radon, have not been 5 
fully examined. Objective: In this study, we aimed to compare the biological effects of 6 
radon and thoron inhalation on mouse organs with a focus on oxidative stress. Methods: 7 
Male BALB/c mice were randomly divided into 15 groups: sham inhalation, radon 8 
inhalation at a dose of 500 Bq/m3 or 2000 Bq/m3, and thoron inhalation at a dose of 500 9 
Bq/m3 or 2000 Bq/m3 were carried out. Immediately after inhalation, mouse tissues were 10 
excised for biochemical assays. Results: The results showed a significant increase in 11 
superoxide dismutase and total glutathione, and a significant decrease in lipid peroxide 12 
following thoron inhalation under several conditions. Additionally, similar effects were 13 
observed for different doses and inhalation times between radon and thoron. Conclusion: 14 
Our results suggest that thoron inhalation also exerts antioxidative effects against oxidative 15 
stress in organs. However, the inhalation conditions should be carefully analyzed because 16 
of the differences in physical characteristics between radon and thoron. 17 
Keywords: radon; thoron; oxidative stress; antioxidative function 18 
Introduction 19 
The inert gas, radon (222Rn), is a natural alpha-emitter emanated from soil and dwellings and is a dominant 20 
source of exposure to ionizing radiation. Exposure to radon is known to cause lung cancer because of the 21 
deposition of its progenies in the lung, bronchi, and alveoli. This is supported by experimental evidences 22 
from cohort studies and biological experiments using cell culture and laboratory animals (Al-Zoughool and 23 
Krewski 2009; Pershagen et al. 1994; World Health Organization 2009). 24 
Inhaled radon and its progenies are transported to organs through blood circulation and expose 25 
them to ionizing radiation. Reactive oxygen species (ROS) such as hydroxyl radicals (OH-) isolated from 26 
biomolecules damage DNA, proteins, and lipids in organs or tissues. This is called oxidative stress and is 27 
known to be related to various diseases. Cells exposed to oxidative stress also acquire resistance to the 28 
stress. Antioxidants like superoxide dismutase (SOD) and glutathione are involved in this effect as radical 29 
scavengers. Oxidative stress is known to be induced by many factors including physical exercise, 30 
psychological stress, and radiation. Organs have antioxidative functions to mitigate oxidative stress, and 31 
radon therapy activates them. This phenomenon is called radio-adaptive response and has been used for 32 
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therapy (Otsuka et al. 2006; Yamaoka et al. 1991). According to the previous studies, it could be induced 1 
by low dose irradiation at doses of approximately 0.01 to 0.5 Gy (Tapio S et al. 2007). Using this 2 
phenomenon, radon has been traditionally applied for treatment against oxidative stress-related diseases 3 
such as rheumatic diseases (Falkenbach et al. 2005; Franke et al. 2000), osteoarthritis (Yamaoka et al. 2004), 4 
and bronchial asthma (Mitsunobu et al. 2003) in some regions including Badgastein (Austria) and Misasa 5 
(Japan). The evidence and mechanism of this therapy remained unclear for a long time. However, ROS 6 
related pathways in cells were recently examined using laboratory animals. SOD can be synthesized via 7 
nuclear factor-kappa B (NF-κB)-related pathways. A previous study reported the possibility that radon 8 
inhalation activates this pathway, thus increasing SOD activity (Kataoka et al. 2017). 9 
Radon has a radioactive isotope, 220Rn, called thoron. Because of its short half-life (55.6 sec), the 10 
influence of thoron on the human body has been underestimated. However, after detecting high-thoron 11 
background regions, researchers have focused on the effects of inhaled thoron (Ramola et al. 2012). Menon 12 
et al. (2014) examined changes in antioxidative functions including expression of SOD and reduced 13 
glutathione (GSH) in mouse organs by thoron inhalation at a high concentration of approximately 500 14 
kBq/m3 within 30 days of inhalation. The results showed a significant increase in DNA damage of lung 15 
tissue, and significant decrease in some antioxidants. In contrast, according to the data from a clinical trial 16 
on thoron and thermal therapy, mitigation effects on oxidative stress in humans were observed. The therapy 17 
was performed at a concentration of 5 kBq/m3 for 40 min per day, every 2 days for 3 weeks (Kataoka et al. 18 
2006). From the above results, we hypothesized that if the exposure conditions including concentration and 19 
inhalation times are adjusted, thoron inhalation also has mitigation effects against oxidative stress. It can 20 
be considered that due to the significant difference of physical half-lives of thoron (55.6 sec) and radon (3.8 21 
days), the distribution of radon, thoron and their progenies in the body was different following radon and 22 
thoron inhalation even under the same conditions of concentration and inhalation time. This might influence 23 
absorbed doses in organs, and consequently - radical production. 24 
In this study, we exposed mice to radon and thoron using a small thoron inhalation system as well 25 
as our ready-made radon inhalation system (Ishimori et al. 2010) and compared the changes in antioxidants 26 
and ROS-related biomarkers. In addition, we varied the inhalation conditions by varying the concentrations 27 
and inhalation times for each nuclide and aimed to identify the optimal conditions for antioxidative effects. 28 
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Our results provide not only new insights into the influence of internal exposure of low-dose 1 
irradiation by radon and thoron but is also relevant to thoron therapy which has been conventionally 2 
performed in some regions without any scientific evidence. 3 
Materials and Methods 4 
Thoron inhalation system 5 
The thoron source was provided by SanteCrear CO., LTD (Aichi, Japan) and included natural minerals rich 6 
in thorium-series nuclides. Before the animal experiment, we empirically confirmed that the radon 7 
emanation from this source was negligibly small compared to the thoron emanation. 8 
A small thoron inhalation system was assembled and composed as shown in Fig. 1. Thoron source 9 
containers, air pumps (MPΣ30, SIBATA, Japan), Lucas scintillation cells (300A, PYLON, Canada), 10 
counting assemblies (AB-5, PYLON, Canada), and breeding cages were properly connected by tubes. 11 
Indoor air and thoron gas were mixed in thoron source containers and were continuously flowed into the 12 
scintillation cells and breeding cages through air pumps at a flow rate of 2 L/min. To eliminate the influence 13 
of thoron progenies, breeding cages and scintillation cells were equipped with HEPA filters and membrane 14 
filters, respectively, and glass filters were placed on the inlet side. The analysis of thoron concentration was 15 
calculated based on previous studies (Sakoda et al. 2015, 2016). Thoron has a short half-life, as mentioned 16 
above, and its decay correction in the system was performed accordingly.  17 
Radon gas inhalation system 18 
Radon inhalation was carried out by the radon exposure system previously developed by our group and was 19 
composed as shown in Fig. 2. Because the source of radon is natural soil, thoron gas was also released into 20 
the atmosphere. To remove coexisting thoron in radon atmosphere, a decay chamber (0.2 m3) was installed. 21 
The radon concentration in the breeding cages was measured by radon monitors (AlphaGUARD PQ200 22 
PRO, SAPHYMO, Germany). To eliminate the influence of radon progenies, breeding cages and 23 
scintillation cells were equipped with HEPA filters and membrane filters, respectively, and glass filters 24 




Male BALB/c mice (8 weeks of age, body weight 25–30 g) were purchased from CLEA Japan Inc. (Tokyo, 1 
Japan). The mice were housed in plastic cages under controlled conditions of temperature (average 21.6°), 2 
humidity (average 79.0%), and light (12 h light, 12 h dark) and were fed food and water ad libitum. Ethics 3 
approval for all protocols and experiments was obtained from the Animal Experimental Committee of 4 
Okayama University. 5 
Radon and thoron inhalation 6 
Mice were randomly divided into 15 groups (n = 6 for each group): (1) sham inhalation only (Control), 7 
radon inhalation at a doses of (2) 500 Bq/m3 (Rn500) or (3) 2000 Bq/m3 (Rn2000), and thoron inhalation 8 
at a doses of (4) 500 Bq/m3 (Tn500) or (5) 2000 Bq/m3 (Tn2000). The mice were exposed to air only, radon, 9 
or thoron for 1, 2, or 4 days and were given free access to food and water during the inhalation. Immediately 10 
after inhalation, mice were euthanized by excessive carbon dioxide inhalation, and blood was drawn from 11 
the heart for serum analysis. The brain, lung, liver, pancreas, and kidney were quickly excised for use in 12 
biochemical assays. 13 
Biochemical assay 14 
SOD activity was assayed by the nitroblue tetrazolium (NBT) reduction method using the Wako-SOD test 15 
(Wako Pure Chemical Industry, Co., Ltd., Osaka, Japan), according to the manufacturer’s recommendations 16 
(Baehner et al. 1975). The brain, lung, liver, pancreas, and kidney were homogenized on ice in 10-mM 17 
phosphate buffer (PBS; pH 7.4). Briefly, the homogenates were centrifuged at 12,000×g for 45 min at 4°C, 18 
and supernatants were used to assay SOD activity. The extent of inhibition of the reduction in NBT was 19 
measured at 560 nm using a spectrophotometer. One unit of enzyme activity was defined as 50% inhibition 20 
of NBT reduction. 21 
Lipid peroxide (LPO) levels were measured using the Bioxytech LPO-586TM assay kit (OXIS 22 
Health Products, Inc., OR, USA) according to the manufacture’s recommendations. Briefly, samples were 23 
homogenized on ice in 10-mM phosphate buffered saline (PBS; pH 7.4). Prior to homogenization, 10 μL 24 
of 0.5-M butylated hydroxytoluene in acetonitrile was added per 1 mL buffer-tissue mixture. The 25 
homogenate was centrifuged at 15,000×g for 10 min at 4°, and the supernatant was then used for assay. 26 
This assay is based on the reaction between a chromogenic reagent, N-methyl-2-phenylindole, and 27 
malondialdehyde and 4-hydroxyalkenals at 45°. The data are derived from the optical density of colored 28 
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products at 586 nm. 1 
The total glutathione (t-GSH) content was measured using the Bioxytech GSH-420 assay kit 2 
(OXIS Health Products, Inc., Portland, OR, USA). Briefly, tissue samples were suspended in 10-mM PBS 3 
(pH 7.4), mixed with ice-cold 7.5% trichloroacetic acid solution and then homogenized. The homogenates 4 
were centrifuged at 3,000×g for 10 min. The supernatant was used for the assay. T-GSH content was 5 
measured at 420 nm using a spectrophotometer. This assay is based on the formation of a chromophoric 6 
thione, the absorbance of which, measured at 420 nm, is directly proportional to t-GSH concentration. 7 
The protein content in each sample measured by the Bradford method (Bradford 1976) using the 8 
Protein Quantification Kit-Rapid (Dojindo Molecular Technologies, Inc., Kumamoto, Japan). 9 
Statistical analyses 10 
The data are presented as the mean ± standard deviations (SD). Each experimental group consisted of 11 
samples of six animals. The one-way ANOVA test was used to evaluate the dose dependency of biological 12 
effects. Dunnet’s test was used for multiple comparisons. P values were considered significant at P < 0.05. 13 
Results 14 
Measurement of radon and thoron in the inhalation systems 15 
Fig. 3 shows time-dependent changes in radon and thoron concentrations in breeding cages during 16 
the experiment. The mean concentrations were 501 Bq/m3 in the Rn500 group, 1951 Bq/m3 in the Rn2000 17 
group, 599 Bq/m3 in the Tn500 group, and 2045 Bq/m3 in the Tn2000 group. The relative standard deviation 18 
was approximately 10% in the Rn500 and Rn2000 groups, approximately 20% in the Tn500 group, and 19 
approximately 5% in the Tn2000 group.  20 
Fig. 4 shows the comparison between measurements and calculated alpha-ray counts by radon, 21 
thoron, and their progenies in scintillation cells after the gas flow was shut off. This data indicates that there 22 
was no contamination of thoron atmosphere by radon gas. 23 
Changes in SOD activities in mouse organs following radon and thoron inhalation 24 
SOD is a catalytic substance that catalyzes superoxide anions (O2-.) generated in organs to form hydrogen 25 
peroxide (H2O2) and oxygen (O2). Our group has already shown the possibility that radon inhalation can 26 
increase SOD activity at therapeutic concentrations (Kataoka et al. 2014; Nishiyama et al. 2012, 2016). 27 
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Therefore, by adjusting the inhalation conditions we tested the hypothesis that thoron also has similar 1 
effects on antioxidative functions. We assayed the SOD activity in mouse organs following thoron 2 
inhalation and explored the optimal therapeutic conditions. Results showed significant increases in SOD 3 
activity in mouse brain (P < 0.05), pancreas (P < 0.05), and kidney (P < 0.05) compared with control mice 4 
under specific conditions of 500 or 2000 Bq/m3 within 2 days of inhalation. In contrast, SOD activity in 5 
mouse organs in radon inhalation groups was not significantly altered compared with control mice (Fig. 5). 6 
Changes in t-GSH content in mouse organs following radon and thoron inhalation 7 
Following disproportionation by SOD, hydrogen peroxide remains to produce hydroxyl radical (OH-.), the 8 
most reactive free radical. Glutathione peroxidase (GPx) plays an important role in the removal of hydroxyl 9 
radical by t-GSH. Therefore, we next evaluated changes in t-GSH contents in mouse organs. Results 10 
showed a significant increase in t-GSH contents in the livers of mice from the Tn500 (P < 0.01) and Tn2000 11 
(P < 0.01) groups. T-GSH contents in Tn2000 mice also showed an increasing trend, although no significant 12 
difference was observed. These trends were observed within 1 day of inhalation. In contrast, t-GSH contents 13 
in the liver (P<0.01) and plasma (P<0.05) were significantly decreased after 2 or 4 days of thoron inhalation. 14 
These dose- and inhalation time-dependent trends were not significantly different between radon and thoron 15 
(Fig. 6). 16 
Changes in LPO levels in mouse organs following radon and thoron inhalation 17 
LPO is generated by the reaction between lipid and ROS and is used as a biomarker of oxidative stress. In 18 
contrast, LPO could be directly removed by t-GSH. To evaluate the mitigation effects by thoron inhalation 19 
against oxidative stress, we assayed LPO levels in mouse organs. Results showed a significant decrease of 20 
LPO level in mouse liver (P < 0.01), pancreas (P < 0.05), and kidney (P < 0.01) compared with control 21 
mice under specific conditions, i.e., in Tn500 or Tn2000 mice within 2 days of inhalation. LPO levels in 22 
Tn500 mouse brain also showed a decreasing trend, although there was no significant difference. These 23 
time-dependent changes in LPO levels were similar to those caused by radon inhalation. In contrast, under 24 
specific conditions, significant increases in LPO levels were observed, i.e., in Tn2000 mouse livers (1 day, 25 




As described above, multiple conditions for each inhalation group could be regulated by new- and 1 
previously developed systems. Coexistence of radon and thoron might not influence the biological effects 2 
because the concentrations were at background level. In some conditions and organs, significant increases 3 
in antioxidant (SOD and t-GSH) levels and significant decreases in indicators of oxidative stress (LPO) 4 
were shown after thoron inhalation. And these effects were mainly observed within 1-2 days of inhalation. 5 
In contrast, significant decreases in t-GSH content in the liver, pancreas and plasma and a significant 6 
increase in LPO level in the liver were also shown in thoron inhalation groups. According to the previous 7 
report of radon inhalation, antioxidative effects tend to be elevated especially 1-2 days after the inhalation. 8 
They are temporarily decreased and gradually returned to the original level after several days (Kataoka et 9 
al. 2011). These trends were also observed in the results of this study. Additionally, dose- and time-10 
dependent changes of these indicators were different between radon and thoron inhalation. 11 
These findings suggest that thoron may have antioxidative effects on organs and tissues similar to 12 
those observed for radon inhalation. However, these effects were induced by different exposure conditions 13 
between radon and thoron. From the perspective of intracellular pathways, it has been reported that radon 14 
and its progenies exert oxidative stress on cells and may activate pathways related to one of the nuclear 15 
transcription factors, NF-κB. These pathways can be activated by intracellular ROS generation and DNA 16 
damage and are thought to contribute to the induction of Mn-SOD (Kataoka et al. 2017). Thoron inhalation 17 
is also a factor that exerts oxidative stress to cells and activation of antioxidative function may occur via 18 
the same pathways under radon inhalation.  19 
There are some possibilities regarding how these gaps in changing characteristics of oxidative 20 
stress and antioxidants were observed between radon and thoron. First, dose conversion factors described 21 
in the UNSCEAR report 2000 have different values between radon (6-15 nSv (Bq h m-3)-1) and thoron (40 22 
nSv (Bq h m-3)-1). This gap might be induced by different biological effects on organs (United Nations 23 
2000). In this study, Tn500 mice showed similar but insignificant changes in SOD, t-GSH, and LPO levels 24 
when compared with the levels in several organs of Rn2000 mice. Especially in the brain, the time-25 
dependent changes in SOD and LPO levels were not comparable between Tn500 and Rn2000 mice. In 26 
contrast, the changes exhibited by the Tn2000 mice were not consistent with any other inhalation groups. 27 
It can be speculated that the inhalation conditions of the Tn2000 group induced higher oxidative stress in 28 
organs. Furthermore, the equilibrium between antioxidative effects and oxidative stress might have been 29 
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temporarily disturbed. These results suggest that similar antioxidative effects may be induced by thoron 1 
inhalation at lower concentrations than radon in specific organs. Second, there might be differences 2 
between radon and thoron inhalation in the pharmacokinetics of the progenies and in the energy provided 3 
to tissues. The effective half-life of radon has been reported to be about 30 minutes, and it is thought that 4 
unattached radon and its progeny is absorbed at a faster rate into blood than the attached radon progeny 5 
(Butterweck et al. 2002). Absorbed dose by radon inhalation has been computed by Sakoda et al. (2010). 6 
In this calculation, it was assumed that radon and the short half-life progenies simultaneously decayed, and 7 
alpha-ray energy of 222Rn (5.490 MeV), 218Po (6.003 MeV), and 214Po (7.687 MeV) was considered. In 8 
contrast, following alpha decay of thoron, 216Po rapidly decays and releases an alpha particle (6.78 MeV) 9 
with a half-life of 0.145 s to become 212Pb which has a half-life of 10 hours. Subsequently, alpha particles 10 
are emitted by the decaying of 212Bi (6.051 MeV) and 212Po (8.784 MeV). Thus, it could be necessary to 11 
consider the pharmacokinetics of long-lived nuclides such as 212Pb in thoron inhalation. From the above 12 
discussion, it is speculated that because of the higher alpha-ray energy and differences in pharmacokinetics 13 
of their progenies, thoron inhalation might provide equivalent biological effects at lower concentrations 14 
compared with radon. 15 
Focusing on the changes in antioxidants and LPO levels in each organ, the results showed a 16 
tendency to mitigate oxidative stress, especially in the brain, liver, pancreas, and kidney. Significant 17 
changes in t-GSH were observed only in the liver, and an increase in SOD was observed in the brain, 18 
pancreas, and kidney. Although t-GSH mainly has a direct reducing effect on LPO, other antioxidants are 19 
considered to indirectly suppress the chained generation of radicals. In these organs, beneficial effects were 20 
observed mainly in the inhalation group within 2 days, and tendencies to decrease antioxidants and increase 21 
oxidative stress were observed in several organs in the 4-day inhalation groups. As shown in the previous 22 
studies on radon therapy in mice, radon inhalation is performed for approximately 24 hours at the 23 
concentration of 500 to 2000 Bq/m3. The concentration used for actual treatment for humans is about 44 24 
kBq/m3 in Badgastein and about 2000 Bq/m3 in Misasa, and inhalation is performed for about 40 minutes 25 
a day for 3 to 4 weeks on alternate days. As mentioned above, conditions for obtaining beneficial effects 26 
have been set empirically for radon therapy. Similarly, in the case of thoron inhalation, it is necessary to 27 
identify the appropriate inhalation conditions. The results of this study, in which concentration-time 28 
conditions were set in a matrix, may be helpful for appropriate thoron administration for therapy. 29 
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There were several difficulties in clarifying the mechanisms on how these antioxidative effects are 1 
induced. To investigate these mechanisms in more detail, the pharmacokinetics of each nuclide should be 2 
analyzed by measurement or calculation. However, the mechanisms may have been undetectable under our 3 
experimental conditions and oxidation stimulation to organs might have been too small to detect significant 4 
changes. This may be caused by the low-dose of radon irradiation of 0.04–1.4 nGy (Bqm-3)-1day-1 (Sakoda 5 
et al. 2010). Additionally, there are various factors that affect oxidative stress, including radiation dose, 6 
alcohol intake, and smoking. To separate these factors appropriately, cell-culture assays must be performed 7 
in biological experiments. In this study, because of the characteristics of the experiment for radon inhalation, 8 
it was necessary to use laboratory animals. In addition, to consider the stress derived from the living 9 
environment, we used control groups for each inhalation day.  10 
In conclusion, this is the first report to compare the changes in antioxidant function and oxidative 11 
stress by radon and thoron inhalation at the concentration used for therapeutic purposes. Our results suggest 12 
that thoron inhalation also exerts antioxidative effects in organs. However, some organs did not show a 13 
decrease in LPO, and other antioxidants like catalase also need to be examined. In further studies, the 14 
inhibitory effect on oxidative stress-related diseases should be examined similar to radon therapy. 15 
Furthermore, we emphasize that the pharmacokinetics of each radionuclide by thoron inhalation remain 16 
unclear. Thus, it must be confirmed that organs are not exposed to unnecessary irradiation beyond the dose 17 
required for obtaining beneficial effects. 18 
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Fig. 1 The composition of the thoron gas inhalation system. 2 




Fig. 2 The composition of the radon gas inhalation system.  2 
 3 




Fig. 3 Changes of radon and thoron concentrations during the experiment. (a) Radon group, (b) Thoron 2 
group. 3 
 4 




Fig. 4 Measurements and calculated alpha-ray counts from 220Rn or 222Rn and their progenies in 2 
scintillation cells after the gas flow was shut off. (a) Tn500 group, (b) Tn2000 group. 3 
 4 




Fig. 5 Dose- and time- dependent changes in SOD activities in mouse organs following radon or thoron 2 
inhalation. Mean ±SD, N=6, *P<0.05 vs Control  3 
 4 




Fig. 6 Dose- and time- dependent changes in t-GSH contents in mouse organs following radon or thoron 2 
inhalation. Mean ±SD, N=6, *P<0.05, **P<0.01 vs Control 3 
 4 




Fig. 7 Dose- and time- dependent changes in LPO levels in mouse organs following radon or thoron 2 
inhalation. Mean ±SD, N=6, *P<0.05, **P<0.01, ***P<0.001 vs Control 3 
